Type 1 Diabetes
Francis S. Collins: Genetic data poised to revolutionize landscape of diabetes care
SAN DIEGO — Genetic data gleaned from an ongoing “-omics” revolution are providing new insights for the prevention and treatment of diabetes that will dramatically change clinical care within the next 10 years, according to a speaker.
Closed-loop systems linked to higher time in range for children with type 1 diabetes
CHICAGO — Children with type 1 diabetes using closed-loop insulin delivery systems spend more time in range than those receiving insulin injections or using a sensor-augmented pump or continuous glucose monitor, according to study data.
FDA clears next-generation insulin pump with algorithm-based insulin dosing software
The FDA had granted clearance for a next-generation automated insulin dosing system for people with type 1 diabetes, according to a press release.
Time in range similar with fast-acting vs. standard insulin for young kids with diabetes
Fast-acting insulin aspart delivered through a hybrid closed-loop insulin delivery system provided similar glycemic outcomes as standard insulin aspart for young children with type 1 diabetes, according to study data.
VIDEO: Genetic predisposition suggested in stiff-person syndrome
BOSTON — An evaluation of the Utah Population Health Database showed familial clustering of stiff-person syndrome along with other autoimmune diseases, Justin Abbatemarco, MD, said at the American Academy of Neurology annual meeting.
FDA approves next-generation advanced hybrid closed-loop insulin delivery system
The FDA approved an advanced hybrid-closed loop insulin pump that provides automated real-time insulin corrections for the user, according to a press release.
Insulin degludec noninferior to insulin detemir for pregnant women with type 1 diabetes
Pregnant women with type 1 diabetes who were treated with insulin degludec had a similar reduction in HbA1c as those using insulin detemir, according to findings published in The Lancet Diabetes & Endocrinology.
Intensive diabetes management does not preserve C-peptide in youths with type 1 diabetes
Older children with newly diagnosed type 1 diabetes who received intensive diabetes management with automated insulin delivery had no difference in pancreatic C-peptide levels compared with standard care, according to study data.
Top in endocrinology: Gut microbiome and diabetes risk; COVID-19 exposure and weight gain
Children who were diagnosed with type 1 diabetes had differences in their gut microbiome at age 1 year from those without diabetes, according to recent data.
Cognitive behavioral therapy-based intervention reduces diabetes distress for adults
A cognitive behavioral therapy multidisciplinary intervention was associated with a reduction in HbA1c and improvements in diabetes distress for adults with type 1 and type 2 diabetes, according to study findings.